Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Torrey Pines unveils new EchoTherm programmable 5-position stirring hot plate
, /in Product News /by panglobalTorrey Pines Scientific has unveiled its new EchoTherm Model HS65 Programable Digital Stirring Hot Plate with five stirring positions for use in chemical, pharmaceutical, environmental, biochemical, and other laboratories.
Micronic’s tube decapper boosts lab productivity
, /in Product News /by panglobalTargeting the ever-growing requirement for higher sample throughput, the robust Push Cap Decapper CP620 from Micronic enables labs tasked with opening multiple sample storage tubes with TPE Septum Caps to achieve significant productivity gains.
BioPharma Dynamics expands portfolio of cell media solutions for the cell and gene therapy industry
, /in Product News /by panglobalBioPharma Dynamics, a leading life sciences solution provider, has expanded their extensive portfolio for the cell and gene therapy market to offer a range of chemically defined T-cell media, DMSO-free cryopreservation solutions, and recombinant growth factors.
Fast and simple retrieval of whole tissue samples
, /in Product News /by panglobalThe new Mohawk 48 tube selector and picker from Ziath is designed to select and pick wide, heavy, or tall tubes – making it perfect for retrieving individual whole tissue samples from storage. This new system uses 48 solenoid pins to enable a specific frozen or thawed sample tube to be raised and selected when […]
Calypso Biotech begins dosing of first Eosinophilic Esophagitis patient in trial of CALY-002
, /in E-News /by panglobalCalypso Biotech, a leader in the development of Interleukin-15 (IL-15) targeted therapies, has begun dosing of the first Eosinophilic Esophagitis patient in the multiple dosing part of the Phase 1 clinical trial of CALY-002, a novel humanized – and highly differentiated – monoclonal antibody neutralizing IL-15. The ongoing Phase 1 clinical study of CALY-002 includes […]
ProtonDx appoints new head of sales for European commercial expansion
, /in E-News /by panglobalProtonDx, an in vitro diagnostics company designing, manufacturing and marketing rapid, accurate, multi-pathogen, point-of-need diagnostic solutions, has appointed Leigh Howes as its new head of sales.
SOTIO exercises option for novel antibody-drug conjugate with LegoChem Biosciences
, /in E-News /by panglobalSOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first of five exclusive, target-specific options with LegoChem Biosciences for antibody-drug conjugate (ADC) SOT106, which is currently being evaluated in preclinical studies across a multitude of solid tumour indications.
Nykode Therapeutics and Richter-Helm BioLogics form strategic manufacturing partnership
, /in E-News /by panglobalNykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, has entered into a strategic manufacturing partnership with Richter-Helm BioLogics to supply plasmid DNA for Nykode’s wholly owned and partnered product portfolio.
BARDA issues $19M contract to Hologic to support IVD approval of COVID assays
, /in E-News /by panglobalHologic has been awarded a US$19 million contract from the U.S.-based Biomedical Advanced Research and Development Authority (BARDA) to support research and development efforts for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Aptima SARS-CoV-2 assay.
Researchers scale production of designer immune cells for drug discovery
, /in E-News /by panglobalTo prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells. However, the availability of cells like these has been limited to date. Now, Fraunhofer researchers have succeeded in scaling the production of customized immune cells from laboratory up to industrial level.